Indian Journal of Critical Care Medicine

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Related articles

VOLUME 9 , ISSUE 1 ( January, 2005 ) > List of Articles

EDITORIAL

Recombinant activated factor VII for acute intracerebral hemorrhage

Sudhir Kumar

Citation Information : Kumar S. Recombinant activated factor VII for acute intracerebral hemorrhage. Indian J Crit Care Med 2005; 9 (1):11-13.

DOI: 10.4103/0972-5229.16262

License: CC BY-ND 3.0

Published Online: 01-01-2005

Copyright Statement:  Copyright © 2005; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract


PDF Share
  1. Venketasubramanian N. The epidemiology of stroke in ASEAN countries- A review. Neurol J Southeast Asia 1998;3:9-14.
  2. Mendelow AD, Gregson BA, Fernandes HM, Murray GD, Teasdale GM, Hope DT, et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the International Surgical Trial in Intracerebral Haemorrhage (STICH): A randomised trial. Lancet 2005;365:387-97.
  3. Kiyohara Y, Kubo M, Kato I, Tanizaki Y, Tanaka K, Okubo K, et al. Ten-year prognosis of stroke and risk factors for death in a Japanese community: the Hisayama study. Stroke. 2003;34: 2343-7.
  4. Woo D, Sauerbeck LR, Kissela BM, Khoury JC, Szaflarski JP, Gebel J, et al. Genetic and environmental risk factors for intracerebral hemorrhage: Preliminary results of a population-based study. Stroke 2002;33:1190-5.
  5. Mayer SA, Brun NC, Begtrup K, Broderick J, Davis S, Diringer MN, et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005;352:777-85.
  6. Brott T, Broderick J, Kothari R, Barsan W, Tomsick T, Sauerbeck L, et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997;28:1-5.
  7. Becker KJ, Baxter AB, Bybee HM, Tirschwell DL, Abouelsaad T, Cohen WA. Extravasation of radiographic contrast is an independent predictor of death in primary intracerebral hemorrhage. Stroke 1999;30:2025-32.
  8. Morgenstern LB, Demchuk AM, Kim DH, Frankowski RF, Grotta JC. Rebleeding leads to poor outcome in ultra-early craniotomy for intracerebral hemorrhage. Neurology 2001;56:1294-9.
  9. Friederich PW, Henny CP, Messelink EJ, Geerdink MG, Keller T, Kurth KH, et al. Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: A double-blind placebo-controlled randomised trial. Lancet 2003;361:201-5.
  10. Lindley CM, Sawyer WT, Macik BG, Lusher J, Harrison JF, Baird-Cox K, et al. Pharmacokinetics and pharmacodynamics of recombinant factor VIIa. Clin Pharmacol Ther 1994;55:638-48.
  11. He S, Blomback M, Ekman GJ, Hedner U. The role of recombinant factor VIIa (FVIIa) in fibrin structure in the absence of FVIII/FIX. J Thromb Haemost 2003;1:1215-9.
  12. Sorensen B, Johansen P, Nielsen GL, Sorensen JC, Ingerslev J. Reversal of the International Normalized Ratio with recombinant activated factor VII in central nervous system bleeding during warfarin thromboprophylaxis: Clinical and biochemical aspects. Blood Coagul Fibrinolysis 2003;14:469-77.
  13. Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia. A patients with inhibitors. Am J Hematol 1994;47:36-40.
  14. Arkin S, Cooper HA, Hutter JJ, Miller S, Schmidt ML, Seibel NL, et al. Activated recombinant human coagulation factor VII therapy for intracranial hemorrhage in patients with hemophilia A or B with inhibitors. Results of the novoseven emergency-use program. Haemostasis 1998;28:93-8.
  15. Vidarsson B, Onundarson PT. Recombinant factor VIIa for bleeding in refractory thrombocytopenia. Thromb Haemost 2000;83: 634-5.
  16. No authors listed. Use of recombinant activated factor VII (NovoSeven) in treatment of patients with idiopathic thrombocytopenic purpura complicated with subarachnoid and parenchimatous hemorrhage. Lik Sprava 2004;7:77-81.
  17. Carrick MM, Tyroch AH, Youens CA, Handley T. Subsequent development of thrombocytopenia and coagulopathy in moderate and severe head injury: Support for serial laboratory examination. J Trauma 2005;58:725-30.
  18. Morenski JD, Tobias JD, Jimenez DF. Recombinant activated factor VII for cerebral injury-induced coagulopathy in pediatric patients. Report of three cases and review of the literature. J Neurosurg 2003;98:611-6.
  19. Worth LL, Hoots WK. Development of a subdural vein thrombosis following aggressive factor VII replacement for postnatal intracranial haemorrhage in a homozygous factor VII-deficient infant. Haemophilia 1998;4:757-61.
  20. NovoSeven prescribing information. http://www.us.novoseven.com/content/us_vers/us_prescribing_ information.asp (accessed on March 17, 2005)
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.